National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

April 22, 2022

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 87 Issue 78 (Friday, April 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 78 (Friday, April 22, 2022)]
[Notices]
[Page 24183]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-08612]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Division of 
Intramural Research Board of Scientific Counselors, National Institute 
of Allergy and Infectious Diseases.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(4) and 
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual intramural programs and projects conducted by 
the NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Division of Intramural Research Board of 
Scientific Counselors, NIAID.
    Date: June 13-15, 2022.
    Time: 8:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Rocky Mountain 
Laboratories, 903 South 4th Street, Hamilton, MT 59840.
    Contact Person: Steven M. Holland, MD, Ph.D., Chief, Laboratory 
of Clinical Infectious Diseases, National Institutes of Health/
NIAID, Hatfield Clinical Research Center, Bethesda, MD 20892-1684, 
301-402-7684, <a href="/cdn-cgi/l/email-protection#46352e292a2a272822062b272f2a68282f2e68212930"><span class="__cf_email__" data-cfemail="25564d4a4949444b416548444c490b4b4c4d0b424a53">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: April 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-08612 Filed 4-21-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on April 22, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.